Clinical trial No longer in our active list Interventional Ages 18 and up

Using a bioinductive graft to treat large rotator cuff tears

Official title: A Prospective, Randomized Evaluation of Bioinductive Augmentation for High Risk Rotator Cuff Tears

Run by Nova Scotia Health Authority · NCT04248751 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new type of graft to see if it can help people with large rotator cuff tears heal better and reduce the chances of needing more surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment76 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Locations1 site (Halifax, Nova Scotia)
Trial IDNCT04248751 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with MRI-confirmed large rotator cuff tears resulting from trauma or degeneration.

Probably not a fit

Patients with specific shoulder conditions, such as subscapular tears or glenohumeral osteoarthritis, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a bioinductive graft in treating large rotator cuff tears greater than 3 cm, which are often difficult to repair surgically. Patients with confirmed large rotator cuff tears will undergo surgical intervention involving debridement and the application of the graft. The goal is to improve healing rates and reduce the high re-tear rates associated with traditional surgical techniques. The study will assess patient outcomes in terms of pain relief and functional improvement post-surgery.

Why it matters

Potential benefit: If successful, this approach could significantly enhance healing rates and reduce the likelihood of re-tears in patients with large rotator cuff injuries.

How similar studies have gone: While there have been various surgical techniques for rotator cuff repair, the use of bioinductive grafts is a relatively novel approach that has not been extensively tested in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Magnetic resonance imaging (MRI) proven diagnosis of a large \>3cm tear of the shoulder rotator cuff in a competent adult (\>18 years of age).

Exclusion Criteria:

* Patients with subscapular tear
* Glenohumeral osteoarthritis
* A normalized WORC score \>70 (where scores range between 0-100, and 100 is the best outcome)
* Uncontrolled diabetes (Hgb A1C \>7%)
* Pregnancy
* Presence of local or systemic infection
* Inability to cooperate with and/or comprehend post-operative instructions
* Nonvascular surgical sites (MRI proven)
* Poor nutritional state (Alb \<30 g/L)
* Cancer
* Paralysis of the shoulder
* Contracture of the shoulder
* Presence of cuff tear arthropathy or osteoarthritis of the shoulder
* Patients unable to provide informed consent for the study

Where it's running

  • Nova Scotia Health Authority
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

  • Principal investigator: Ivan Wong, MD — Orthopaedic Surgeon
  • Study coordinator: Sara Sparavalo, MASc
  • Email: sara@drivanwong.com
  • Phone: 9024734251

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Rotator cuff repair using a FiberLocker patch to reinforce the tendon

    This will try a FiberLocker patch to strengthen arthroscopic rotator cuff repairs in adults aged 40–65 with traumatic full‑thickness supraspinatus (± infraspinatus) tears.

    Recruiting ZuriMED Technologies AG · Zurich, Canton of Zurich · NCT07005063

  • Long-term follow-up of FX Shoulder Solutions implants

    This follow-up will track adults who receive FX Shoulder Solutions hemi or total shoulder replacements to see if the implants need revision and how well shoulder function and pain hold up over 10 years.

    Recruiting at 22 sites FX Solutions · Amiens and 21 other locations · NCT07558590

  • Wearable-guided home rehabilitation after rotator cuff repair

    This tests whether a wearable-device remote rehabilitation program helps adults recovering from small-to-medium rotator cuff surgery regain shoulder function better than traditional in-person rehab.

    Recruiting Peking University Third Hospital · Beijing · NCT07412184

  • Pillow Brace to Improve Sleep After Rotator Cuff Surgery

    This study tests a pillow-backed brace to help people sleep better after arthroscopic rotator cuff repair.

    Recruiting GCS Ramsay Santé pour l'Enseignement et la Recherche · Paris · NCT07009379

  • FiberLocker® augmentation for rotator cuff repair

    This study will test whether adding the FiberLocker® System (SpeedPatch® PET plus FiberLocker® Instrument) to arthroscopic repair improves healing and shoulder function in adults 30–70 with full-thickness rotator cuff tears of at least 2 cm.

    Recruiting at 4 sites ZuriMED Technologies Inc. · Chicago, Illinois and 3 other locations · NCT06918041

  • Comparing two techniques for biceps tendon treatment during shoulder surgery

    This study is testing two different surgical methods for treating a tendon in the shoulder during rotator cuff repair to see which one works better and has fewer complications.

    Recruiting Clinique Générale dAnnecy · Annecy · NCT06774820

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.